Are you Nitrosamine Ready? Solutions for Nitrosamine Analysis

Nitrosamine Analysis Made Simple: Achieve Compliance with Shimadzu Mass Spectrometry

Nitrosamine impurities are a growing concern in the pharmaceutical industry due to their toxicity and strict regulatory limits. This webinar will showcase how Shimadzu’s high-sensitivity LC-MS and GC-MS platforms help streamline nitrosamine detection in complex matrices, reduce method development time, and ensure compliance with FDA, EMA, and ICH M7 guidelines. Through expert insights and real-world examples, you’ll learn how to implement efficient workflows for your QA/QC and R&D labs.

Learning Objectives:

• An overview of current regulatory requirements for nitrosamine testing (USP and FDA)
• Challenges in detecting nitrosamines in complex pharmaceutical matrices.
• How Shimadzu’s LC-MS and GC-MS systems deliver high sensitivity and reliable results.
• Streamlined workflows techniques to reduce analysis time.
• Real-world case studies demonstrating successful nitrosamine analysis in QA/QC and R&D.

Who should attend:

• Pharma QA/QC
• Pharma R&D
• Regulatory Affair in need to comply with nitrosamines analysis

Presenter: Kevin Wons (Market Manager - Pharma/BioPharma, Shimadzu Scientific Instruments)

Kevin is the Market Manager for Pharma/BioPharma at Shimadzu Scientific Instruments. Prior to that, Kevin worked in Analytical R&D in biopharma for over 6 years, with experience in characterization for biologics. He also has over 3 years of experience in the academia field doing neuroscience research.